High expression of AKR1B10 predicts low risk of early tumor recurrence in patients with hepatitis B virus-related hepatocellular carcinoma.

Sci Rep · 2017 · PMC5299837 · PMID 28181486

Europe PMC DOI

hedged sentence

0.1010

closest p · 2.0× alpha

0.1010

boldest claim

The sentences

did not achieve significanceP = 0.101not close (p > 0.1)

Among patients with BCLC stage B or C disease, DFS rates still tended to be higher among those with high AKR1B10 expression but the difference did not achieve significance ( P = 0.101; Fig. 3C ).

also in 1,397 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.